Timely and accurate diagnosis is fundamental to ensuring effective treatment of health conditions and improved human health. Access to quality, authentic medicine is crucial to treating and curing disease and ensuring quality of life for millions of chronic diseases sufferers across Bangladesh.
Reaching 8 million patients and vulnerable people
AKS Khan Pharmaceuticals (AKPL) is Bangladesh’ leading chain pharmacy operator and is currently expanding their pharmacy chain to 80 locations and 30 new diagnostics. The investment from Impact Fund Denmark enables AKPL ro reach 8 million patients annually within five years, while scaling up innovative services, indluding home Xray and ultrasound for vulnerable and elderly patients.
Additionally, the funds will support AKPL to roll out a wide range of programs on clinical quality and patient service, enhancing the quality and reliability of diagnostic services and medicines available to patients.
Expanding access across Bangladesh
major component of the growth strategy will focus on increasing the company’s presence beyond the capital Dhaka. This expansion is crucial for ensuring that underserved patients of Bangladesh gain improved access to quality healthcare.